Young Americans' Cigarette Use Drops as Marijuana and E-Cigarette Use Rises

Dec.01.2022
Young Americans' Cigarette Use Drops as Marijuana and E-Cigarette Use Rises
Young Americans are smoking less cigarettes and turning to marijuana and e-cigarettes instead, according to Gallup study.

According to new data released by research firm Gallup, cigarettes appear to be losing their appeal among young people in the United States, as they now prefer to smoke marijuana or use electronic cigarettes.


This week, a US research company released new data regarding the tobacco consumption of young Americans aged 18 to 29. According to the findings, cigarette consumption among young people has significantly decreased from 35% to 12% over the past 20 years. Moreover, the number of young people who use marijuana now exceeds those who smoke cigarettes by more than two-fold.


According to the report, there has been a decline of 23 percentage points among young people, which is more than twice the decline seen in any other age group during the same time period. As a result of these changes, young people have shifted from being the most likely group to smoke to the second least likely group, with only the oldest Americans having a lower smoking rate.


Vaping and smoking weed have become more common activities among young people. Data shows that in fact, they are shifting from traditional cigarettes to e-cigarettes and cannabis.


The decrease in young people smoking traditional cigarettes is occurring simultaneously with an increase in the usage of marijuana and electronic cigarettes.


Between 2019 and 2022, an average of 26% of young people admitted to using marijuana, compared to a proportion of 17% between 2013 and 2015.


However, electronic cigarettes are also replacing traditional cigarettes among young people, as 15% of individuals aged 18 to 29 only use electronic cigarettes, while only 8% exclusively smoke traditional cigarettes.


Overall, 27% of the American population surveyed by Gallup report using cigarettes, e-cigarettes, or marijuana.


The age group of 18 to 29 prefers to only smoke marijuana (9%), followed by e-cigarettes (7%), while only 3% of the respondents said they only smoke cigarettes.


The use of marijuana has increased among adults aged 30 to 64, while it remains stable among the elderly population.


According to a report by Gallup, an increasing number of young people are using marijuana, "possibly because more and more states have legalized marijuana and e-cigarettes.


At first glance, recent research supports this analysis, as it has found that in states that regulate recreational marijuana sales, usage of marijuana has increased.


In August, a study published in the journal "Addiction" indicated that individuals residing in states where cannabis is legal consume the substance at a rate 20% higher than those residing in states where cannabis is illegal.


However, due to a lack of official data, it may be difficult to track actual consumption in states in the United States that do not have standardized legal markets. Even in states where marijuana is legal, tracking overall consumption may still be a challenge, as the illegal market continues to thrive.


A study published last year in JAMA Pediatrics reported on the use of electronic cigarettes to consume marijuana by adolescents. The study showed that over the past seven years, the number of teenagers consuming marijuana through e-cigarettes has doubled.


However, several factors may have contributed to the decrease in tobacco consumption among young people and the increase in marijuana use, including the anti-tobacco movement that has lasted for several years, a change in the method of using marijuana, and the propaganda efforts to eliminate the stigma surrounding marijuana.


Despite recreational marijuana use still being illegal at the federal level, over 21 states in the past decade have legalized marijuana.


Therefore, the normalization of marijuana use may lead to an increase in the number of young people using marijuana in the short term.


The US annual substance use survey released in August 2022 revealed that daily cannabis use has reached "the highest level since trend monitoring began in 1988.


This survey confirms Gallup's analysis, as it emphasizes that although the usage of e-cigarettes decreased during the first few months of the pandemic in 2020, there has been a significant increase in e-cigarette usage among young people in 2021. Additionally, it also reveals the prevalence of marijuana use among young people in the past month.


Further Reading:


Organizing proposals related to electronic cigarettes and marijuana in the United States midterm elections.


2FIRSTS will continue to report on this topic and updates will be available on the '2FIRSTS APP.' Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Global Starts Debt Refinancing Four Months After Nasdaq Listing With About $400 Million Notes Expected
AIR Limited, a wholly owned subsidiary of AIR Global, has launched an offering of U.S. dollar-denominated senior unsecured notes, with proceeds primarily intended to repay its existing term loan and revolving credit facility. AIR has not disclosed the final size, maturity or coupon; Refinitiv, citing Moody's, reported an expected issuance of approximately $400 million and a Ba3 rating. AIR had about $412.4 million outstanding under the two bank facilities at June 30 and net debt of $344.8 million. In the first half of 2026, AIR's Al Fakher-led flavored shisha molasses business generated about 99% of company revenue, while New Growth Categories including Crown Switch produced $2.2 million in revenue and remained loss-making on an adjusted EBITDA basis.
Sep.23
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
SMOORE’s DOJO by VAPORESSO to Launch New Global Brand Identity on September 1
According to recent LinkedIn posts from people at VAPORESSO, SMOORE and a German distribution partner, vape brand DOJO will begin rolling out a new global brand identity on September 1, 2026, led by a redesigned handwritten logo. The new visual system will be gradually applied across product packaging, marketing materials and digital assets over the following months. Fabio Corsaro, Head of Marketing and Purchasing at MG Wesel GmbH, said the rebrand was related to trademark issues, but that explanation has not been publicly confirmed by DOJO, VAPORESSO or SMOORE. DOJO is currently promoting its Blast X product in Germany.
Aug.31
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
The UK’s Vaping Products Duty (VPD), scheduled to take effect in October 2026, is prompting retailers to assess how different vape categories may be affected. UK retailer Vape HQ has estimated potential price changes under the new volume-based tax system, showing that 100ml shortfill e-liquids could see prices rise from around £12.99 to £39.39, a 203% increase, while 2ml prefilled pod vape kits could rise from £5.99 to £6.52, an increase of about 9%. The estimates highlight how a volume-based tax structure creates uneven cost impacts across product categories.
Aug.19
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives